Yang Li

5PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 31, 2025
Correction to "Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy".

Yang Li, Yun Liu, Dan Zhang

|Apr 20, 2022
Discovery of 4-Hydroxyquinazoline Derivatives as Small Molecular BET/PARP1 Inhibitors That Induce Defective Homologous Recombination and Lead to Synthetic Lethality for Triple-Negative Breast Cancer Therapy.

Jifa Zhang, Chengcan Yang, Pan Tang

|Mar 24, 2022
Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development.

Juncheng Chen, Pan Tang, Yuxi Wang

|Aug 05, 2021
Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer.

Yang Li, Gaoxia Yang, Jifa Zhang

|Dec 14, 2019
Synthesis, characterization and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and EGFR downregulation.

Yun-Mei Liu, Yang Li, Rong-Fang Liu

Pageof 1

Frequent Collaborators

4 joint publications

Liang Ouyang

2 joint publications

Yuxi Wang

1 joint publications

Guan Wang

1 joint publications

Jifa Zhang